Zenicure Labs

ZENIBET‑16 is a purpose‑built Betahistine 16 mg formulation crafted to restore vestibular balance, clarity, and day‑to‑day confidence for patients living with vertigo, Ménière’s disease, and chronic imbalance. In a segment where fear, uncertainty, and lifestyle disruption dominate the patient’s emotional landscape, ZENIBET‑16 positions itself as a steadying force—a brand that brings patients back to their center.

Together, ZENIBET‑16 communicates a promise of peak balance, peak clarity, and peak control—a message that resonates strongly with neurologists, ENT specialists, and general practitioners.

Betahistine remains the cornerstone therapy for vestibular disorders due to its dual mechanism: • Enhancing microcirculation in the stria vascularis and improving endolymphatic flow • Accelerating central vestibular compensation for long‑term stability

ZENIBET‑16 builds on this foundation with a formulation optimized for smooth absorption, predictable plasma levels, and excellent tolerability, making it suitable for both acute episodes and long‑term maintenance. Patients often describe vertigo as a spinning world, a collapsing sense of orientation, or a sudden loss of control. ZENIBET‑16 aims to break this cycle by offering a steady, dependable daily partner that helps them regain confidence in movement, posture, and routine activities.

The brand identity is calm yet authoritative—reflecting both the serenity patients seek and the clinical reliability doctors demand. ZENIBET‑16 is positioned not just as a medicine but as a restoration brand, helping patients reclaim their balance, productivity, and peace of mind. Its messaging emphasizes stability, clarity, and continuity, making it ideal for chronic vestibular care.

In practice, ZENIBET‑16 supports recovery in conditions such as recurrent vertigo, vestibular neuritis, Ménière’s disease, tinnitus‑associated imbalance, and post‑labyrinthitis instability. Its consistent action helps reduce the frequency, intensity, and unpredictability of vertigo episodes, allowing patients to move through their day without fear of sudden disruption.

For prescribers, ZENIBET‑16 represents a trusted, familiar, and clinically aligned choice—a brand that fits seamlessly into neuro‑ENT treatment pathways. For patients, it represents control, calm, and confidence.

ZENIBET‑16 stands as a symbol of restored equilibrium—helping individuals rise above dizziness, reclaim their rhythm, and return to life with clarity and steadiness.

Varifly supplement contains flavonoids that may be beneficial for Vein health.
Support to reduce Swelling of Vein and promotes blood flow. it helps to improve the strength of veins and reduces permeability.
Aescin, the active ingredient in horse chestnut, which helps tone the walls of the veins, helps to improve the flow of blood back to the heart.

Horse chestnut extract also helps to relieve swelling.

This combination tablet (Betahistine + Vitamin D3 + Ginkgo Biloba + Piracetam + Vinpocetine) is a neuroprotective and supportive formulation often used in conditions related to the brain, nerves, and balance. Each ingredient contributes a specific therapeutic role:

📌 Key Uses

• Vertigo & Balance Disorders

  • Betahistine improves blood flow in the inner ear, reducing dizziness and vertigo.

• Cognitive Support & Memory Enhancement

  • Piracetam and Vinpocetine enhance brain metabolism, improve focus, and support memory in age‑related cognitive decline.

• Neuroprotection

  • Ginkgo Biloba improves cerebral blood circulation and acts as an antioxidant, protecting nerve cells.

• Bone & Nerve Health

  • Vitamin D3 supports calcium absorption, bone strength, and neuromuscular function.

• Stroke Recovery & Dementia Support

  • Combination may be used as adjunct therapy in ischemic stroke rehabilitation, dementia, and Alzheimer’s disease.

• Tinnitus (Ringing in the Ear)

  • Betahistine + Ginkgo Biloba together help reduce inner ear pressure and improve microcirculation.